Status:
UNKNOWN
Effect of Magnesium Supplementation on Patients With Diabetic Nephropathy
Lead Sponsor:
Isfahan University of Medical Sciences
Conditions:
Diabetes
Eligibility:
All Genders
9-12 years
Phase:
NA
Brief Summary
This is a double-blind randomized clinical trial which will start at June 2014 and end on June 2015 in Isfahan city. Serum creatinine level is considered as a key variable and the sample size calculat...
Detailed Description
This is a double-blind randomized clinical trial which will start at June 2014 and end on June 2015 in Isfahan city. Serum creatinine level is considered as a key variable and the sample size calculat...
Eligibility Criteria
Inclusion
- more than 18 years old
- diabetic nephropathy
- Fasting Blood Sugar more than 126 milligram per deciliter
- Proteinuria 30-300 milligram per deciliter (microalbuminuria)
- Glomerular Filtration Rate more than 90 milliliter per minute
- Not having hyperthyroidism or hypothyroidism
- Not having any feverish urinary tract infection
- Not using any kind of drug including Cigarette
- Not having any liver disease
- Not having any cancer and inflammatory diseases
- Not having more than 4 kilogram weight loss during last 3 months
- Not using any magnesium-rich supplement
Exclusion
- changing medicine dose
- Not having adherence (using less than 75 percent of medicines)
- Cardiac Arrhythmias
Key Trial Info
Start Date :
June 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2014
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT02220036
Start Date
June 1 2014
End Date
October 1 2014
Last Update
August 19 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Isfahan University of Medical Sciences
Isfahan, Isfahan, Iran